Showing results (21-30 of 32) with videos related to
Sort By:
Pageof 4
Journal of Clinical Medicine|August 27, 2021
The Role of Demographics, Social Deprivation and Ethnicity on Anal Squamous Cell Carcinoma Incidence in EnglandDanielle R L Brogden, Christos Kontovounisios, Sundhiya Mandalia, et al.JCO Oncology Practice|November 16, 2020
All You Need to Know About DPYD Genetic Testing for Patients Treated With Fluorouracil and Capecitabine: A Practitioner-Friendly GuideFederico Innocenti, Sarah C Mills, Hanna Sanoff, et al.American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|March 28, 2024
Implementation of CYP2C19 and CYP2D6 genotyping to guide antidepressant use in a large rural health systemNatasha J Petry, Joel Van Heukelom, April J Schultz, et al.International Journal of Colorectal Disease|September 26, 2020
Evaluating the efficacy of treatment options for anal intraepithelial neoplasia: a systematic reviewDanielle R L Brogden, Una Walsh, Gianluca Pellino, et al.Pharmacogenomics|August 28, 2019
Implementation of wide-scale pharmacogenetic testing in primary careNatasha Petry, Jordan Baye, Aissa Aifaoui, et al.Updates in Surgery|September 5, 2021
Comparing and contrasting clinical consensus and guidelines for anal intraepithelial neoplasia in different geographical regionsDanielle R L Brogden, Micol E E Lupi, Oliver J Warren, et al.Journal of Crohn'S & Colitis|March 24, 2023
Risks Factors Associated with the Development of Crohn's Disease After Ileal Pouch-Anal Anastomosis for Ulcerative Colitis: A Systematic Review and Meta-AnalysisMichael G Fadel, Georgios Geropoulos, Oliver J Warren, et al.Pharmacogenomics|July 17, 2023
Attitudes about pharmacogenomic testing vary by healthcare specialtyCharlene L Preys, Carrie L Blout Zawatsky, Amanda Massmann, et al.Pharmacogenomics|May 26, 2023
SLCO1B1 gene-based clinical decision support reduces statin-associated muscle symptoms risk with simvastatinAmanda Massmann, Joel Van Heukelom, Robert C Green, et al.European Journal of Human Genetics : EJHG|February 29, 2024
Clinical impact of preemptive pharmacogenomic testing on antiplatelet therapy in a real-world settingAmanda Massmann, Kurt D Christensen, Joel Van Heukelom, et al.Pageof 4